http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102233647-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10 |
| filingDate | 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102233647-B1 |
| titleOfInvention | Peptide AEC1D for skin regenerating or wound healing and use thereof |
| abstract | The present invention relates to a peptide AEC1D for skin regeneration or wound treatment and a use thereof. The novel synthetic peptide (AEC1D) according to the present invention increases the amount of collagen synthesis by fibroblasts, so that it has excellent regeneration and wound healing effects on damaged skin.It is a very small-scale peptide composed of 6 amino acids and is low molecular and biodegradable. Since the residual period in the body is not long, the possibility of causing hypersensitivity reactions is low, so the side effects of the administration of external substances can be minimized, so it is expected that it can be used as an effective substance that can replace the existing preparations for skin regeneration or wound treatment. . |
| priorityDate | 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.